CT
Coeptis Therapeutics Holdings, Inc.
SEC filingPharmaceuticals · Wexford, PA
Amount raised$4Msold at filing
Total offering$5M$1M still open
Investors in the raise9count reported to the SEC
FiledAug 7, 2025first sale Jul 24, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Christopher CochranDirector
David MehalickExecutive Officer, Director
Christopher CaliseDirector
Tara Maria DeSilvaDirector
Daniel YeraceDirector
Brian CogleyExecutive Officer
Gene Maria SalkindDirector
Philippe Maria DeschampsDirector
Executive officers, directors and promoters as listed on the Form D.